Acetaminophen vs Indomethacin in Treating hsPDA

ClinicalTrials.gov ID: NCT03537144

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03537144. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison of the Efficacy of IV Acetaminophen Versus IV Indomethacin in Treatment of Hemodynamically Significant PDA in VLBW Infants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if acetaminophen (Tylenol) is as effective as indomethacin in closing patent ductus arteriosus in premature infants.

Study identification

NCT ID: NCT03537144
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 3
Lead sponsor: University of Tennessee; Other
Enrollment: 37 participants

Conditions and interventions

Conditions

Patent Ductus Arteriosus

Interventions

Indomethacin Drug
Acetaminophen Drug

Drug

Eligibility (public fields only)

Age range: 22 Weeks to 32 Weeks
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2016 (Actual)
Primary completion: Sep 2018 (Actual)
Completion: Sep 2018 (Actual)
Last update posted: Dec 3, 2019

2016 – 2018

United States locations

U.S. sites: 3
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
LeBonheur Children's Hospital	Memphis	Tennessee	38103	—
Methodist-Lebonheur Germantown Hospital	Memphis	Tennessee	38138	—
Regional One Health	Memphis	Tennessee	38163	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03537144, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 3, 2019 · Synced Nov 15, 2026